Protega pharmaceuticals collaborates with wellgistics to support pharmacist education and increase patient access to the first and only fda-approved abuse-deterrent immediate-release opioid, roxybond™

Roxybond, formulated with patented, first-of-its-kind abuse-deterrent technology sentrybond ™ , is designed to provide multiple levels of protection

WGRX Ratings Summary

WGRX Quant Ranking